-
Breaking Linguistic Barriers: Cross-Language HEOR & Evidence Integration Through GenAI
Mar 10, 2025, 14:00 PM -
One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals
Mar 10, 2025, 14:00 PM -
An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis
Mar 10, 2025, 14:00 PM -
Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Dominican Republic
Mar 10, 2025, 14:00 PM -
Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Canada’s Evolving Market for Biosimilars and What It Means for Payers
Mar 10, 2025, 14:00 PM -
Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review
Mar 10, 2025, 14:00 PM -
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Patients with Itch-Dominant Moderate-to-Severe Atopic Dermatitis Treated in Private Dermatology Facilities in the United States
Mar 10, 2025, 14:00 PM -
Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints
Mar 10, 2025, 14:00 PM -
Burden of Administration: Belamaf Based Combinations (BVd, BPd) Versus Carfilzomib Based Combinations (IsaKd, DKd, Kd)
Mar 10, 2025, 14:00 PM -
From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU
Mar 10, 2025, 14:00 PM -
Pharmacometric-Pharmacoeconomic Modeling and Simulation to Assess Target Product Profile Characteristics in Early Drug Development: Application to Atopic Dermatitis
Mar 10, 2025, 14:00 PM -
Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States
Mar 10, 2025, 14:00 PM -
A Contemporary Analysis of Utilization, Clinical Outcomes and Costs of Robotic-Assisted, Laparoscopic, and Open Partial Nephrectomy Using the National Inpatient Sample
Mar 10, 2025, 14:00 PM -
Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study
Mar 10, 2025, 14:00 PM -
Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study
Mar 10, 2025, 14:00 PM -
Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review
Mar 10, 2025, 14:00 PM